<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1551">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05140967</url>
  </required_header>
  <id_info>
    <org_study_id>ABW-2021-CF</org_study_id>
    <nct_id>NCT05140967</nct_id>
  </id_info>
  <brief_title>Effects of Training Intensity on Physical Fitness and Body Composition in Cystic Fibrosis</brief_title>
  <official_title>Effects of Endurance Training Intensity on Exercise Capacity, Body Composition, and Appetite Regulation in Cystic Fibrosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Kiel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fachklinik Satteldüne der DRV Nord</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Kiel, Arbeitsbereich Sportmedizin und Trainingswissenschaften</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Kiel</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aim of the randomized controlled trial is to investigate the effects of endurance training&#xD;
      with different intensities on physical performance, body composition and appetite regulation&#xD;
      in people with cystic fibrosis.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">October 15, 2021</start_date>
  <completion_date type="Anticipated">September 2024</completion_date>
  <primary_completion_date type="Anticipated">September 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change in Peak Oxygen Uptake</measure>
    <time_frame>at baseline and after 4 weeks of exercise training program</time_frame>
    <description>measured with peak Oxygen uptake (VO2) in percent predicted</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change in Peak Workload</measure>
    <time_frame>at baseline and after 4 weeks of exercise training program</time_frame>
    <description>measured with peak Workload in percent predicted</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change body fat mass index</measure>
    <time_frame>at baseline and after 4 weeks of exercise training program</time_frame>
    <description>measured with body fat mass index (FMI) in kg / m*2</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change in Body fat free mass index</measure>
    <time_frame>at baseline and after 4 weeks of exercise training program</time_frame>
    <description>measured with fat free body mass index (FFMI) in kg / m*2</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>change in Forced Expiratory Volume in 1 second</measure>
    <time_frame>at baseline and after 4 weeks of exercise training program</time_frame>
    <description>measured with Forced Expiratory Volume in 1 second (FEV1) in percent predicted</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in Health related quality of life</measure>
    <time_frame>at baseline and six and twelve months after completion of exercise training program</time_frame>
    <description>measured with the Cystic Fibrosis Questionnaire Revised (CFQ-R); 9 Quality of life domains: Physical, role/school, vitality, emotion, social, body image, eating, treatment burden, health perceptions: 3 symptom scales: Weight, respiratory, and digestion Scores range from 0 to 100, with higher scores indicating better health.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>appetite control - subjective feeling of hunger</measure>
    <time_frame>at baseline and after 4 weeks of exercise training program</time_frame>
    <description>measured with visual analogue scales. The scale consists of a 10 cm vertical line anchored with &quot;not hungry at all&quot; at the left side and with &quot;extremely hungry&quot; at the right side.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Cystic Fibrosis</condition>
  <arm_group>
    <arm_group_label>High Intensity Interval Training (A)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Exercise training with intermittent bouts of high intensity</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Moderate Intensity Continous Training (B)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Exercise training with constant workload</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High Intensity Interval Training (HIIT)</intervention_name>
    <description>High Intensity Interval Training</description>
    <arm_group_label>High Intensity Interval Training (A)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Moderate Continuous Intensity Training (MICT)</intervention_name>
    <description>Moderate Intensity Continuous Training</description>
    <arm_group_label>Moderate Intensity Continous Training (B)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  confirmed diagnosis of cystic fibrosis by at least 2 sweat tests and / or by the&#xD;
             presence of two CF mutations,&#xD;
&#xD;
          -  willingness to participate in and to comply with the research project procedure,&#xD;
&#xD;
          -  written informed consent of patients,&#xD;
&#xD;
          -  age ≥ 18 years,&#xD;
&#xD;
          -  FEV1 of pred. ≥ 40%,&#xD;
&#xD;
          -  Stable condition (as indicated by absence of one or more signs: new or increased&#xD;
             haemoptysis, increased malaise, fatigue or lethargy, temperature over 38°C, weight&#xD;
             loss, sinus pain and a decrease in pulmonary function by 10% or more)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Severe pulmonary exacerbation,&#xD;
&#xD;
          -  cor pulmonale,&#xD;
&#xD;
          -  musculoskeletal discomfort that makes a regular exercise training impossible,&#xD;
&#xD;
          -  untreated CF-related diabetes,&#xD;
&#xD;
          -  multidrug resistance organism: Multi-resistant gram-negative bacteria (MRGNB);&#xD;
             methicillin-resistant Staphylococcus aureus (MRSA)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anja Bosy-Westhphal, Prof, PhD, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Insitute of Human Nutrition, University of Kiel</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Fachklink Satteldüne der DRV Nord</name>
      <address>
        <city>Nebel / Amrum</city>
        <state>Schleswig-Holstein</state>
        <zip>25946</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>December 2021</verification_date>
  <study_first_submitted>October 29, 2021</study_first_submitted>
  <study_first_submitted_qc>December 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 2, 2021</study_first_posted>
  <last_update_submitted>December 1, 2021</last_update_submitted>
  <last_update_submitted_qc>December 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Kiel</investigator_affiliation>
    <investigator_full_name>Prof. Dr. Dr. Anja Bosy-Westphal</investigator_full_name>
    <investigator_title>Prof. Dr. Dr. Anja Bosy-Westphal</investigator_title>
  </responsible_party>
  <keyword>Exercise training</keyword>
  <keyword>High Intensity Interval Training (HIIT)</keyword>
  <keyword>Moderate Intensity Continuous Training (MICT)</keyword>
  <keyword>Exercise capacity</keyword>
  <keyword>Peak Oxygen uptake (VO2peak)</keyword>
  <keyword>Body-composition</keyword>
  <keyword>Subjective appetite and satiety ratings</keyword>
  <keyword>Appetite regulating hormones</keyword>
  <keyword>Health related quality of life</keyword>
  <keyword>Habitual physical activity</keyword>
  <keyword>ad libitum energy intake</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cystic Fibrosis</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

